Article | August 4, 2021

Role Of Organic Co-Solvent (t-Butanol) In Frozen And Freeze-Dried Formulations

Vial with powder

In the last year, more than 40% of drugs approved by the FDA have been lyophilized1. Lyophilization stabilizes the drug product and enables a longer shelf life at room temperature with easier transportation.

However, the processing steps (freezing, primary drying and secondary drying) involved in the lyophilization process can expose the proteins to various stress and harsh conditions, leading to denaturation, aggregation and sometimes a loss of functionality. To overcome these stresses experienced by protein throughout freezing, drying and storage use of cryo- or lyo-protectants in certain ratios is a central theme in formulation development.

Recently, Jayesh Sonje, a Ph.D. candidate from Dr. Raj Suryanarayanan’s lab at the University of Minnesota, USA presented a webinar that examined the thermal characterization of an organic solvent, tert-Butyl alcohol (TBA) used as an excipient during the freeze-drying process. This tech note summarizes the webinar and includes a selection of questions from the Q&A sessions.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: